查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1706790

犬异位性皮肤炎市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Canine Atopic Dermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 242 Pages | 商品交期: 2-10个工作天内

价格

犬特应性皮肤炎市场-报告范围

TMR 关于全球犬异位性皮肤炎市场的报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2019 年至 2035 年期间全球犬异位性皮肤炎市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年全球犬异位性皮肤炎市场的年复合成长率(CAGR%)。

该报告是经过广泛研究后编写的。初步研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了访谈。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解犬异位性皮肤炎市场。

市场概况
2024 年的市场价值 2.314亿美元
2035年的市场价值 4.31亿美元
复合年增长率 5.8%

该报告深入探讨了全球犬异位性皮肤炎市场的竞争格局。我们已经确定了在全球犬异位性皮肤炎市场中运营的关键参与者，并根据各种属性对每个参与者进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告介绍的全球犬异位性皮肤炎市场参与者的属性。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球市场分析与预测

第五章：关键见解

  • 主要国家医疗支出数据
  • 品牌和定价分析
  • 最新进展
  • 波特五力分析
  • 主要地区/国家的监管格局
  • 针对主要地区/国家新市场进入者的市场进入策略
  • 供应链分析
  • 价值链分析
  • 大环境分析
  • 主要潜在客户

第六章：全球市场分析与预测：依产品类型

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年产品类型市场价值预测
    • 糖皮质激素
    • 免疫抑制剂
    • 单株抗体
    • 钙调神经磷酸酶抑制剂
    • Janus激酶（JAK）抑制剂
    • 其他的
  • 按产品类型分類的市场吸引力

第七章：全球市场分析与预测：依管理途径

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年按给药途径分類的市场价值预测
    • 外用
    • 口服
    • 注射剂
  • 按给药途径分類的市场吸引力

第八章：全球市场分析与预测：按配销通路

  • 介绍与定义
  • 主要发现/进展
  • 2020-2035年配销通路市场价值预测
    • 兽医医院和诊所
    • 兽医药房和药房
    • 电子商务
    • 其他的
  • 配销通路的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各国家/地区市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第十二章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太其他地区

第十三章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 阿根廷
  • 智利
  • 秘鲁
  • 哥伦比亚
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • Zoetis
    • Merck & Co., Inc.
    • Elanco or its affiliates.
    • Boehringer Ingelheim International GmbH
    • Virbac Corporation
    • Vetoquinol
    • TORAY INDUSTRIES, INC.
    • Biocelix
    • Dechra Pharmaceuticals PLC
    • Bioiberica SAU
    • Ceva
    • Bimeda Corporate
    • Other prominent players
Product Code: TMRGL86479

Canine Atopic Dermatitis Market - Scope of Report

TMR's report on the global canine atopic dermatitis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global canine atopic dermatitis market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global canine atopic dermatitis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the canine atopic dermatitis market.

Market Snapshot
Market Value in 2024US$ 231.4 Mn
Market Value in 2035US$ 431 Mn
CAGR5.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global canine atopic dermatitis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global canine atopic dermatitis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global canine atopic dermatitis market.

The report delves into the competitive landscape of the global canine atopic dermatitis market. Key players operating in the global canine atopic dermatitis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global canine atopic dermatitis market profiled in this report.

Key Questions Answered in Global canine atopic dermatitis Market Report:

  • What is the sales/revenue generated by canine atopic dermatitis across all regions during the forecast period?
  • What are the opportunities in the global canine atopic dermatitis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Canine Atopic Dermatitis Market - Research Objectives and Research Approach

The comprehensive report on the global canine atopic dermatitis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global canine atopic dermatitis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global canine atopic dermatitis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Canine Atopic Dermatitis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Canine Atopic Dermatitis Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure Data across Key Countries
  • 5.2. Brand and Pricing Analysis
  • 5.3. Recent Advancements in Canine Atopic Dermatitis
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Regulatory Landscape across Key Regions / Countries
  • 5.6. Go-to-Market Strategy for New Market Entrants across Key Regions / Countries
  • 5.7. Supply Chain Analysis
  • 5.8. Value Chain Analysis
  • 5.9. PESTLE Analysis
  • 5.10. Key Potential Customers

6. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2035
    • 6.3.1. Glucocorticoids
    • 6.3.2. Immunosuppressants
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. Calcineurin Inhibitors
    • 6.3.5. Janus kinase (JAK) Inhibitor
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Topical
    • 7.3.2. Oral
    • 7.3.3. Injectable
  • 7.4. Market Attractiveness By Route of Administration

8. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.2. Veterinary Pharmacies & Drug Stores
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Canine Atopic Dermatitis Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2035
    • 10.2.1. Glucocorticoids
    • 10.2.2. Immunosuppressants
    • 10.2.3. Monoclonal Antibodies
    • 10.2.4. Calcineurin Inhibitors
    • 10.2.5. Janus kinase (JAK) Inhibitor
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2035
    • 10.3.1. Topical
    • 10.3.2. Oral
    • 10.3.3. Injectable
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Veterinary Hospitals and Clinics
    • 10.4.2. Veterinary Pharmacies & Drug Stores
    • 10.4.3. E-commerce
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Canine Atopic Dermatitis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2035
    • 11.2.1. Glucocorticoids
    • 11.2.2. Immunosuppressants
    • 11.2.3. Monoclonal Antibodies
    • 11.2.4. Calcineurin Inhibitors
    • 11.2.5. Janus kinase (JAK) Inhibitor
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020-2035
    • 11.3.1. Topical
    • 11.3.2. Oral
    • 11.3.3. Injectable
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Veterinary Hospitals and Clinics
    • 11.4.2. Veterinary Pharmacies & Drug Stores
    • 11.4.3. E-commerce
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Canine Atopic Dermatitis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2035
    • 12.2.1. Glucocorticoids
    • 12.2.2. Immunosuppressants
    • 12.2.3. Monoclonal Antibodies
    • 12.2.4. Calcineurin Inhibitors
    • 12.2.5. Janus kinase (JAK) Inhibitor
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Topical
    • 12.3.2. Oral
    • 12.3.3. Injectable
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Veterinary Hospitals and Clinics
    • 12.4.2. Veterinary Pharmacies & Drug Stores
    • 12.4.3. E-commerce
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Canine Atopic Dermatitis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2035
    • 13.2.1. Glucocorticoids
    • 13.2.2. Immunosuppressants
    • 13.2.3. Monoclonal Antibodies
    • 13.2.4. Calcineurin Inhibitors
    • 13.2.5. Janus kinase (JAK) Inhibitor
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Topical
    • 13.3.2. Oral
    • 13.3.3. Injectable
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Veterinary Hospitals and Clinics
    • 13.4.2. Veterinary Pharmacies & Drug Stores
    • 13.4.3. E-commerce
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Chile
    • 13.5.5. Peru
    • 13.5.6. Colombia
    • 13.5.7. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Middle East & Africa Canine Atopic Dermatitis Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2035
    • 14.2.1. Glucocorticoids
    • 14.2.2. Immunosuppressants
    • 14.2.3. Monoclonal Antibodies
    • 14.2.4. Calcineurin Inhibitors
    • 14.2.5. Janus kinase (JAK) Inhibitor
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Topical
    • 14.3.2. Oral
    • 14.3.3. Injectable
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Veterinary Hospitals and Clinics
    • 14.4.2. Veterinary Pharmacies & Drug Stores
    • 14.4.3. E-commerce
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Zoetis
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Merck & Co., Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Elanco or its affiliates.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Boehringer Ingelheim International GmbH
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Virbac Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Vetoquinol
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. TORAY INDUSTRIES, INC.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Biocelix
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Dechra Pharmaceuticals PLC
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Bioiberica S.A.U
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Ceva
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Bimeda Corporate
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Other prominent players
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 02: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 03: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 05: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 06: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 07: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 08: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 10: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 11: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 12: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 14: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 15: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 16: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 18: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 19: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 20: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 22: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 23: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 24: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Canine Atopic Dermatitis Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 02: Global Canine Atopic Dermatitis Market Attractiveness Analysis, by Product Type, 2025-2035
  • Figure 03: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Glucocorticoids, 2020-2035
  • Figure 04: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
  • Figure 05: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Monoclonal Antibodies, 2020-2035
  • Figure 06: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Calcineurin Inhibitors, 2020-2036
  • Figure 07: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Janus kinase (JAK) Inhibitor, 2020-2035
  • Figure 08: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 09: Global Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 10: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 11: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Topical, 2020-2035
  • Figure 12: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 13: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Injectable, 2020-2035
  • Figure 14: Global Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 15: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 16: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Hospitals and Clinics, 2020-2035
  • Figure 17: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Pharmacies & Drug Stores, 2020-2035
  • Figure 18: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by E-commerce, 2020-2035
  • Figure 19: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 20: Global Canine Atopic Dermatitis Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 26: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 27: North America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 28: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 29: North America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 33: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 34: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 35: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 36: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 37: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 38: Europe - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 42: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 43: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 44: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 45: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 46: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 47: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 51: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 52: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 53: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 54: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 55: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 56: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 60: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 61: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 62: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 63: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 64: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 65: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035